FDA Label for Siltussin Sa
View Indications, Usage & Precautions
Siltussin Sa Product Label
The following document was submitted to the FDA by the labeler of this product Atlantic Biologicals Corps. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Otc - Active Ingredient
Active Ingredient: Guaifenesin 100 mg (in each 5 mL (teaspoon)(TSP))
Otc - Purpose
Purpose: Expectorant
Indications & Usage
Helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive Uses
Warnings
Otc - Ask Doctor
Ask a doctor before use if you have
- cough that occurs with too much phlegm (mucus)
- cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
Otc - Stop Use
if cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition. Stop use and ask a doctor
Otc - Pregnancy Or Breast Feeding
If pregnant or breast-feeding, ask a health professional before use.
Otc - Keep Out Of Reach Of Children
. In case of overdose, get medical help or contact a Poison Control Center right away. Keep out of reach of children
Directions
- do not take more than 6 doses in any 24-hour period
- repeat dose every 4 hours
adults and children 12 years and over
| 2-4 teaspoonfuls (TSP)
|
children under 12 years | DO NOT USE |
Store at room temperature 20°-25°C (68°-77°F). .
Other information
Do not accept if imprinted tamper evident safety seal around cap is broken or missing
Inactive Ingredients
citric acid, D&C yellow no. 10, FD&C blue no. 1, FD&C red no. 40, strawberry flavor, glycerin, propylene glycol, saccharin sodium, sodium benzoate, sodium citrate, sorbitol, purified water.
Questions
888-974-5279
* Please review the disclaimer below.